Inhalation & Nasal Dosage Manufacturing CDMOs in United States
10 published
10 published CDMOs match Inhalation & Nasal Dosage Manufacturing in United States.
Locations in this set include United States, China, United Kingdom, Belgium, Brazil, and Europe.
Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Antibody-Drug Conjugate (ADC), Biologics (Monoclonal Antibodies), and Cell Therapy.
Matching companies
ArdenaArdena is an integrated CDMO and bioanalytical CRO specializing in advanced drug product development, nanomedicine, and bioanalysis for complex molecules including poorly soluble compounds, highly potent APIs, and controlled substances.
Bend BioscienceU.S. pharmaceutical CDMO offering design, development, and manufacturing of oral solid and liquid dosage forms, from early formulation to commercial-scale production across three domestic locations.
CatalentGlobal CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply.
ExpericSpecialist powder-handling CDMO offering clinical trial supply, development, manufacturing, and packaging services for pharmaceutical products.
HovioneSpecialist integrated CDMO with over 60 years of experience in contract development and manufacturing for pharmaceutical customers, supporting both new and off-patent drug programs.
Kindeva Drug DeliveryPurpose-driven CDMO specializing in injectable, inhalation, and dermal drug delivery with 155,000+ sq. ft. of aseptic operations and fill-finish capabilities.
MedpharmSpecialized CDMO for topical, transdermal, and transepithelial drug products offering formulation development, analytical testing, process scale-up, and GMP manufacturing from early development through commercialization.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
Syngene InternationalInnovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
Unither PharmaceuticalsGlobal CDMO specializing in sterile and non-sterile liquid manufacturing, including Blow-Fill-Seal (BFS) single-dose technology with over 5 billion annual capacity, plus formulation development, analytical services, and ophthalmic expertise across six production sites.
Markdown mirror: /services/inhalation-dosage-manufacturing/us.md